SE517738C2 - Preparat för behandling av allergiska symptom innehållande oljor från Artemisia samt förfarande för dess framställning - Google Patents

Preparat för behandling av allergiska symptom innehållande oljor från Artemisia samt förfarande för dess framställning

Info

Publication number: SE517738C2
Authority: SE; Sweden
Prior art keywords: preparation; essential oils; allergic; plant; plants
Prior art date: 2000-11-22

Application number

SE0004283A

Other languages

English (en)

Swedish (sv)

Other versions

SE0004283L (sv

SE0004283D0 (sv

Inventor

Lars Bjoerk

Thomas Hedner

Per Remberg

Olov Sterner

Original Assignee

Denovastella Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-22

Filing date

2000-11-22

Publication date

2002-07-09

2000-11-22 Application filed by Denovastella Ab filed Critical Denovastella Ab

2000-11-22 Priority to SE0004283A priority Critical patent/SE517738C2/sv

2000-11-22 Publication of SE0004283D0 publication Critical patent/SE0004283D0/xx

2001-11-21 Priority to AT01997310T priority patent/ATE303815T1/de

2001-11-21 Priority to EP01997310A priority patent/EP1335740B1/de

2001-11-21 Priority to CNB018192750A priority patent/CN100560084C/zh

2001-11-21 Priority to AU2426802A priority patent/AU2426802A/xx

2001-11-21 Priority to CA2427964A priority patent/CA2427964C/en

2001-11-21 Priority to US10/432,375 priority patent/US7118770B2/en

2001-11-21 Priority to DK01997310T priority patent/DK1335740T3/da

2001-11-21 Priority to PCT/SE2001/002573 priority patent/WO2002041909A1/en

2001-11-21 Priority to DE60113291T priority patent/DE60113291T2/de

2001-11-21 Priority to ES01997310T priority patent/ES2249493T3/es

2001-11-21 Priority to JP2002544087A priority patent/JP4780899B2/ja

2001-11-21 Priority to AU2002224268A priority patent/AU2002224268B2/en

2002-05-23 Publication of SE0004283L publication Critical patent/SE0004283L/xx

2002-07-09 Publication of SE517738C2 publication Critical patent/SE517738C2/sv

Links

238000002360 preparation method Methods 0.000 title claims abstract description 31
239000003921 oil Substances 0.000 title claims abstract description 20
208000024891 symptom Diseases 0.000 title claims abstract description 14
238000000034 method Methods 0.000 title claims abstract description 12
230000000172 allergic effect Effects 0.000 title claims abstract description 11
208000010668 atopic eczema Diseases 0.000 title claims abstract description 11
240000006891 Artemisia vulgaris Species 0.000 title claims abstract 3
235000003826 Artemisia Nutrition 0.000 title description 3
235000003261 Artemisia vulgaris Nutrition 0.000 title description 3
235000009052 artemisia Nutrition 0.000 title description 3
241000196324 Embryophyta Species 0.000 claims abstract description 32
239000000341 volatile oil Substances 0.000 claims abstract description 25
FJKKZNIYYVEYOL-UHFFFAOYSA-N erythro-cis-Davanon Natural products CC(C)=CCC(=O)C(C)C1CCC(C)(C=C)O1 FJKKZNIYYVEYOL-UHFFFAOYSA-N 0.000 claims abstract description 23
230000000694 effects Effects 0.000 claims abstract description 18
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 17
239000000284 extract Substances 0.000 claims abstract description 13
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
208000006673 asthma Diseases 0.000 claims abstract description 6
239000000126 substance Substances 0.000 claims abstract description 6
230000002048 spasmolytic effect Effects 0.000 claims abstract description 5
206010010744 Conjunctivitis allergic Diseases 0.000 claims abstract description 4
208000002205 allergic conjunctivitis Diseases 0.000 claims abstract description 4
208000024998 atopic conjunctivitis Diseases 0.000 claims abstract description 4
206010039085 Rhinitis allergic Diseases 0.000 claims abstract description 3
201000010105 allergic rhinitis Diseases 0.000 claims abstract description 3
239000000812 cholinergic antagonist Substances 0.000 claims abstract 3
244000042664 Matricaria chamomilla Species 0.000 claims abstract 2
235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract 2
240000002657 Thymus vulgaris Species 0.000 claims abstract 2
208000024780 Urticaria Diseases 0.000 claims abstract 2
201000010435 allergic urticaria Diseases 0.000 claims abstract 2
230000007062 hydrolysis Effects 0.000 claims abstract 2
238000006460 hydrolysis reaction Methods 0.000 claims abstract 2
239000000203 mixture Substances 0.000 claims description 10
WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 5
244000030166 artemisia Species 0.000 claims description 5
238000009835 boiling Methods 0.000 claims description 4
241000894007 species Species 0.000 claims description 4
241000584200 Artemisia thuscula Species 0.000 claims description 3
238000000605 extraction Methods 0.000 claims description 3
229930182470 glycoside Natural products 0.000 claims description 3
150000002338 glycosides Chemical class 0.000 claims description 3
239000007921 spray Substances 0.000 claims description 3
244000249062 Artemisia abrotanum Species 0.000 claims description 2
208000006877 Insect Bites and Stings Diseases 0.000 claims description 2
239000000654 additive Substances 0.000 claims description 2
230000000996 additive effect Effects 0.000 claims description 2
RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 claims description 2
229960005233 cineole Drugs 0.000 claims description 2
238000010411 cooking Methods 0.000 claims description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
244000170514 davana Species 0.000 claims 4
244000215068 Acacia senegal Species 0.000 claims 2
241001469223 Anthocercis littorea Species 0.000 claims 2
241000592656 Artemisia lercheana Species 0.000 claims 2
244000035851 Chrysanthemum leucanthemum Species 0.000 claims 2
235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims 2
240000006550 Lantana camara Species 0.000 claims 2
239000003795 chemical substances by application Substances 0.000 claims 2
239000000470 constituent Substances 0.000 claims 2
235000013624 davana Nutrition 0.000 claims 2
235000015700 Artemisia abrotanum Nutrition 0.000 claims 1
235000007303 Thymus vulgaris Nutrition 0.000 claims 1
239000012675 alcoholic extract Substances 0.000 claims 1
230000009286 beneficial effect Effects 0.000 claims 1
239000000469 ethanolic extract Substances 0.000 claims 1
208000030603 inherited susceptibility to asthma Diseases 0.000 claims 1
238000011084 recovery Methods 0.000 claims 1
239000001585 thymus vulgaris Substances 0.000 claims 1
230000000699 topical effect Effects 0.000 claims 1
238000004519 manufacturing process Methods 0.000 abstract description 3
230000001225 therapeutic effect Effects 0.000 abstract description 3
241000238631 Hexapoda Species 0.000 abstract description 2
206010027654 Allergic conditions Diseases 0.000 abstract 1
235000007866 Chamaemelum nobile Nutrition 0.000 abstract 1
230000003266 anti-allergic effect Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1
LUJAXSNNYBCFEE-UHFFFAOYSA-N 3',4',5-trihydroxy-3,7-dimethoxyflavone Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 6
CCWSQXBMKLEALQ-WMZOPIPTSA-N centaureidin Natural products CO[C@@H]1[C@@H](Oc2cc(O)c(OC)c(O)c2C1=O)c3ccc(OC)c(O)c3 CCWSQXBMKLEALQ-WMZOPIPTSA-N 0.000 description 6
PJQLSMYMOKWUJG-UHFFFAOYSA-N casticin Chemical compound C1=C(O)C(OC)=CC=C1C1=C(OC)C(=O)C2=C(O)C(OC)=C(OC)C=C2O1 PJQLSMYMOKWUJG-UHFFFAOYSA-N 0.000 description 3
BZXULYMZYPRZOG-UHFFFAOYSA-N centaureidin Chemical compound C1=C(O)C(OC)=CC=C1C1=C(OC)C(=O)C2=C(O)C(OC)=C(O)C=C2O1 BZXULYMZYPRZOG-UHFFFAOYSA-N 0.000 description 3
239000010642 eucalyptus oil Substances 0.000 description 3
229940044949 eucalyptus oil Drugs 0.000 description 3
DTPRTOXMYKYSIJ-UHFFFAOYSA-N eupatorin Natural products C1=C(O)C(OC)=CC=C1C1=CC(=O)C2=CC(OC)=C(OC)C=C2O1 DTPRTOXMYKYSIJ-UHFFFAOYSA-N 0.000 description 3
HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 3
150000002216 flavonol derivatives Chemical class 0.000 description 3
235000011957 flavonols Nutrition 0.000 description 3
HKMZDYJMJDPXRP-UHFFFAOYSA-N vitexicarpin Natural products OC1=C2C(C(=C(OC2=CC(=C1OC)OC)C1=CC(=CC(=C1)OC)O)OC)=O HKMZDYJMJDPXRP-UHFFFAOYSA-N 0.000 description 3
LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
241000255925 Diptera Species 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
208000036071 Rhinorrhea Diseases 0.000 description 2
206010039101 Rhinorrhoea Diseases 0.000 description 2
238000001035 drying Methods 0.000 description 2
239000000463 material Substances 0.000 description 2
ZSPZNFOLWQEVQJ-UHFFFAOYSA-N quercetin 3,4'-dimethyl ether Chemical compound C1=C(O)C(OC)=CC=C1C1=C(OC)C(=O)C2=C(O)C=C(O)C=C2O1 ZSPZNFOLWQEVQJ-UHFFFAOYSA-N 0.000 description 2
244000291564 Allium cepa Species 0.000 description 1
235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
206010006784 Burning sensation Diseases 0.000 description 1
241000700198 Cavia Species 0.000 description 1
241000257303 Hymenoptera Species 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
206010042674 Swelling Diseases 0.000 description 1
241000256856 Vespidae Species 0.000 description 1
239000013566 allergen Substances 0.000 description 1
230000007815 allergy Effects 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
230000002921 anti-spasmodic effect Effects 0.000 description 1
235000012813 breadcrumbs Nutrition 0.000 description 1
244000144987 brood Species 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000003172 expectorant agent Substances 0.000 description 1
230000003419 expectorant effect Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
235000013305 food Nutrition 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
229960001340 histamine Drugs 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
230000035778 pathophysiological process Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
235000005875 quercetin Nutrition 0.000 description 1
229960001285 quercetin Drugs 0.000 description 1
235000015096 spirit Nutrition 0.000 description 1
238000005507 spraying Methods 0.000 description 1
230000008961 swelling Effects 0.000 description 1
150000003505 terpenes Chemical class 0.000 description 1
235000007586 terpenes Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medical Informatics (AREA)
Mycology (AREA)
Alternative & Traditional Medicine (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Botany (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SE0004283A 2000-11-22 2000-11-22 Preparat för behandling av allergiska symptom innehållande oljor från Artemisia samt förfarande för dess framställning SE517738C2 (sv)

Priority Applications (13)

Application Number	Priority Date	Filing Date	Title
SE0004283A SE517738C2 (sv)	2000-11-22	2000-11-22	Preparat för behandling av allergiska symptom innehållande oljor från Artemisia samt förfarande för dess framställning
AU2002224268A AU2002224268B2 (en)	2000-11-22	2001-11-21	Method and preparations having effect against allergic symptoms
US10/432,375 US7118770B2 (en)	2000-11-22	2001-11-21	Artemisia extract for treating allergies
PCT/SE2001/002573 WO2002041909A1 (en)	2000-11-22	2001-11-21	Method and preparations having effect against allergic symptoms
CNB018192750A CN100560084C (zh)	2000-11-22	2001-11-21	具有抗过敏症效果的方法和制剂
AU2426802A AU2426802A (en)	2000-11-22	2001-11-21	Method and preparations having effect against allergic symptoms
CA2427964A CA2427964C (en)	2000-11-22	2001-11-21	Method and preparations having effect against allergic symptoms
AT01997310T ATE303815T1 (de)	2000-11-22	2001-11-21	Präparate zur behandlung von allergischen symptomen und deren herstellungsverfahren
DK01997310T DK1335740T3 (da)	2000-11-22	2001-11-21	Præparater med virkning mod allergiske symptomer og fremgangsmåde til fremstilling heraf
EP01997310A EP1335740B1 (de)	2000-11-22	2001-11-21	Präparate zur behandlung von allergischen symptomen und deren herstellungsverfahren
DE60113291T DE60113291T2 (de)	2000-11-22	2001-11-21	Präparate zur behandlung von allergischen symptomen und deren herstellungsverfahren
ES01997310T ES2249493T3 (es)	2000-11-22	2001-11-21	Preparaciones que tienen efecto contra los sintomas alergicos y su metodo de fabricacion.
JP2002544087A JP4780899B2 (ja)	2000-11-22	2001-11-21	アレルギー症状に対して効果を有する調合剤の製造方法

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0004283A SE517738C2 (sv)	2000-11-22	2000-11-22	Preparat för behandling av allergiska symptom innehållande oljor från Artemisia samt förfarande för dess framställning

Publications (3)

Publication Number	Publication Date
SE0004283D0 SE0004283D0 (sv)	2000-11-22
SE0004283L SE0004283L (sv)	2002-05-23
SE517738C2 true SE517738C2 (sv)	2002-07-09

Family

ID=20281923

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0004283A SE517738C2 (sv)	2000-11-22	2000-11-22	Preparat för behandling av allergiska symptom innehållande oljor från Artemisia samt förfarande för dess framställning

Country Status (12)

Country	Link
US (1)	US7118770B2 (de)
EP (1)	EP1335740B1 (de)
JP (1)	JP4780899B2 (de)
CN (1)	CN100560084C (de)
AT (1)	ATE303815T1 (de)
AU (2)	AU2426802A (de)
CA (1)	CA2427964C (de)
DE (1)	DE60113291T2 (de)
DK (1)	DK1335740T3 (de)
ES (1)	ES2249493T3 (de)
SE (1)	SE517738C2 (de)
WO (1)	WO2002041909A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1570838B1 (de) *	2002-12-03	2013-06-12	Pola Chemical Industries Inc.	Dendrit-verlängerungs-inhibitor zur melanozyt und hautzusammensetzung zur äusseren verwendung, umfassend denselben
WO2007004952A1 (en)	2005-07-01	2007-01-11	Denovastella Ab	Antimicrobial and antiinflammatory composition
FR2893252B1 (fr)	2005-11-17	2008-02-15	Engelhard Lyon Sa	Extraits vegetaux stimulant has2
US20080145465A1 (en) *	2006-10-30	2008-06-19	Schmidt Barbara M	Sesquiterpene lactone extract from artemisia leucodes for reducing inflammation and down-regulating pro-inflammatory gene expression
WO2008061536A1 (en) *	2006-11-22	2008-05-29	Ocumedic Aps	Compositions and methods of using same for treatment of a disease or disorder of the eye and/or the adnexa of the eye
EP2263664A1 (de) *	2009-05-18	2010-12-22	Nestec S.A.	Opioid-Rezeptoren stimulierender Wirkstoff (Thymoquinon, Nigella sativa) und Lebensmittelallergie
US20110274776A1 (en)	2010-05-07	2011-11-10	Michael Anthonavage	Compositions comprising extracts of southernwood and an amine compound
CN102309669B (zh) *	2010-07-08	2013-07-03	高健生	一种治疗变态反应性结膜炎的中药制剂
CN103655937A (zh) *	2013-11-26	2014-03-26	宋爱民	治疗急性弥漫性外耳道炎的中药制剂
CN110960565B (zh) *	2018-09-28	2022-02-11	肖斌	一种黑沙蒿根提取物在制备治疗过敏性鼻炎药物中的应用
CN113018445A (zh) *	2020-10-28	2021-06-25	杨永锋	一种预防和缓解过敏性鼻炎的组合物及其制备方法和应用
DE102020006998A1 (de)	2020-11-16	2022-05-19	Hermann-Josef Wilhelm	Verfahren zur Kultivierung einer Pflanze mit mindestens einem antiviralen Wirkstoff, sowie Verwendung des Pflanzeninhaltsstoffes selbst

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE384134C (de) *	1921-05-07	1923-10-25	Chemisch Pharmazeutische Werke	Verfahren zur Herstellung eines Kamillenextraktes
US1926929A (en)	1927-07-02	1933-09-12	Chemisch Pharmazeutische Ag Ba	Modification of the preparation of camomile extracts
DE609884C (de) *	1932-12-22	1935-02-25	Ig Farbenindustrie Ag	Verfahren zur Darstellung von haltbaren Kamillenauszuegen
DE652729C (de) *	1936-08-30	1937-11-06	Ludwig Lendle Dr	Verfahren zur Gewinnung von spasmolytisch wirkenden Inhaltsstoffen aus Thymusarten
CN1067253C (zh) *	1994-03-16	2001-06-20	昆明制药股份有限公司	复方青蒿油外用制剂
FR2751878B1 (fr) *	1996-07-30	1998-09-04	Oreal	Utilisation dans une composition d'un extrait d'au moins une labiee
JPH10139679A (ja) *	1996-11-05	1998-05-26	Noevir Co Ltd	ケミカルメディエーター遊離抑制剤及びこれを含有する化粧料，医薬品並びに食品
JPH10287580A (ja) *	1997-04-10	1998-10-27	Motoo Nishimura	外用剤
JP2000290189A (ja) *	1999-04-09	2000-10-17	Janifu Tekku:Kk	抗アレルギー剤

2000
- 2000-11-22 SE SE0004283A patent/SE517738C2/sv not_active IP Right Cessation
2001
- 2001-11-21 EP EP01997310A patent/EP1335740B1/de not_active Expired - Lifetime
- 2001-11-21 WO PCT/SE2001/002573 patent/WO2002041909A1/en not_active Ceased
- 2001-11-21 ES ES01997310T patent/ES2249493T3/es not_active Expired - Lifetime
- 2001-11-21 US US10/432,375 patent/US7118770B2/en not_active Expired - Lifetime
- 2001-11-21 CA CA2427964A patent/CA2427964C/en not_active Expired - Fee Related
- 2001-11-21 DK DK01997310T patent/DK1335740T3/da active
- 2001-11-21 DE DE60113291T patent/DE60113291T2/de not_active Expired - Lifetime
- 2001-11-21 JP JP2002544087A patent/JP4780899B2/ja not_active Expired - Fee Related
- 2001-11-21 AU AU2426802A patent/AU2426802A/xx active Pending
- 2001-11-21 CN CNB018192750A patent/CN100560084C/zh not_active Expired - Fee Related
- 2001-11-21 AU AU2002224268A patent/AU2002224268B2/en not_active Ceased
- 2001-11-21 AT AT01997310T patent/ATE303815T1/de active

Also Published As

Publication number	Publication date
US20040052875A1 (en)	2004-03-18
JP4780899B2 (ja)	2011-09-28
ATE303815T1 (de)	2005-09-15
CA2427964A1 (en)	2002-05-30
WO2002041909A1 (en)	2002-05-30
ES2249493T3 (es)	2006-04-01
JP2004513968A (ja)	2004-05-13
DK1335740T3 (da)	2006-01-16
SE0004283L (sv)	2002-05-23
DE60113291T2 (de)	2006-08-24
US7118770B2 (en)	2006-10-10
CN1476331A (zh)	2004-02-18
AU2426802A (en)	2002-06-03
DE60113291D1 (de)	2005-10-13
CA2427964C (en)	2011-08-02
SE0004283D0 (sv)	2000-11-22
EP1335740B1 (de)	2005-09-07
CN100560084C (zh)	2009-11-18
EP1335740A1 (de)	2003-08-20
AU2002224268B2 (en)	2006-06-08

Legal Events

Date	Code	Title	Description
2010-06-29	NUG	Patent has lapsed

Publication	Publication Date	Title
Raja	2012	Medicinally potential plants of labiatae (Lamiaceae) family: an
KR20100042337A (ko)	2010-04-26	류머티스관절염 치료제 생약제 조성물 및 그 치료제 제조방법
SE517738C2 (sv)	2002-07-09	Preparat för behandling av allergiska symptom innehållande oljor från Artemisia samt förfarande för dess framställning
US10675252B2 (en)	2020-06-09	Veterinary composition and methods for production and use
US9775872B2 (en)	2017-10-03	Topical pharmaceutical bases for preventing viral diseases
Patra et al.	2022	Flavored food additives on the leaves of Piper betle L.: a human health perspective
AU2002224268A1 (en)	2002-08-08	Method and preparations having effect against allergic symptoms
El Zalabani et al.	2012	Acaricidal activity of Swietenia mahogani and Swietenia macrophylla ethanolic extracts against Varroa destructor in honeybee colonies
Ahmad et al.	2019	Herbo-medicinal formulation; Marham-e-raal: A potent ointment for acute and chronic wounds–A review
Lazăr et al.	2020	Use of essential oils in bees
EP3085356A1 (de)	2016-10-26	Honig mit pflanzenextrakten und herstellungsverfahren dafür
CN102512486B (zh)	2013-08-07	一种防治蜂螨的药物及用途
DE102007006122A1 (de)	2008-08-07	Cistusextrakte
EP1837029B2 (de)	2016-09-21	Zusammensetzung zur Vorbeugung und Behandlung von Erkältungskrankheiten
DE202010013170U1 (de)	2011-04-28	Zusammensetzung aus etherischen Ölen zur Behandlung und bzw. oder Verhütung von Atemwegserkrankungen
RU2086254C1 (ru)	1997-08-10	Бальзамная настойка, обладающая ранозаживляющим, противовоспалительным и антимикробным действием (ее варианты)
Al Mansur et al.	2018	Analgesic, Antidiarrheal and Antidepressant Activities of Anethum sowa Linn. in Swiss-Albino Mice Model
DE60218427T2 (de)	2007-12-20	Verfahren zur gewinnung eines isolierten extrakts aus der pflanze cyclamen europaeum l. und seine verwendung als therapeutisches mittel
Dumitrescu et al.	2021	The antimicrobial activity of a propolis extract.
RU2130713C1 (ru)	1999-05-27	Способ получения меда с повышенной биологической активностью
ITMI20092343A1 (it)	2011-06-30	Composizione battericida e virucida per il cavo orale
HRP20110559A2 (hr)	2013-04-30	Pripravak ljekovitih svojstava u obliku sirupa pogodnog za oralnu primjenu na bazi homogene smjese vodene otopine suhog ekstrakta propolisa, meda u otapalu i ekstrakata ljekovitog bilja
CN120643650A (zh)	2025-09-16	一种用于治疗鼻炎的中药组合物、制剂、制备方法
CN117461659A (zh)	2024-01-30	一种防治蜂螨的中药组合物、药物及其制备方法
WO2015189858A1 (en)	2015-12-17	A synergistic herbal composition useful for the management of diabetes